| 10-1074 |
Rockefeller University/Mass Biologics |
September 2019 |
|
| Ad26.ENVA.01 |
Crucell Holland BV |
June 2013 |
|
| AIDSVAX B/E |
Global Solutions for Infectious Diseases |
March 2016 |
|
| ALVAC-HIV (vCP2438) |
Sanofi Pasteur |
August 2017 |
|
| BG505 SOSIP.664 gp140 |
DAIDS/NIAID/NIH |
October 2019 |
|
| Bivalent Subtype C gp120 with Aluminum Hydroxide Adjuvant |
NIAID/NIH |
June 2015 |
|
| Bivalent Subtype C gp120/AS01B |
GlaxoSmithKline |
July 2016 |
|
| Bivalent Subtype C gp120/MF59 |
GlaxoSmithKline |
July 2016 |
|
| CH505TF gp120 Transient |
DAIDS/NIAID/NIH |
December 2018 |
|
| DNA CON-S env |
DAIDS/NIAID/NIH |
June 2017 |
|
| DNA Mosaic-Tre env DNA Vaccine |
DAIDS/NIAID/NIH |
July 2016 |
|
| DNA-HIV-PT123 |
IPPOX |
January 2019 |
|
| DNA-HIV-PT123/NYVAC-HIV-PT1/NYVAC-HIV-PT4 vaccine |
IPPOX/EuroVacc |
August 2013 |
|
| EnvSeq-1 Vaccine (CH505TF gp120) |
DAIDS/NIAID/NIH |
August 2019 |
|
| GEO-D02 and MVA-HIV62B Vaccine |
GeoVax |
June 2019 |
|
| GEO-D03 and MVA-HIV62B Vaccines (Preventative) |
GeoVax |
June 2013 |
|
| GLA-SE |
Infectious Disease Research Institute (IDRI) |
April 2019 |
|
| Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) |
Dynavax Technologies Corporation |
August 2019 |
|
| HIV-1 Multiantigen pDNA Vaccine and Human IL-12 pDNA |
Profectus BioSciences |
August 2018 |
|
| IHV01 |
Profectus BioSciences Inc. |
March 2019 |
|
